FDA panel loosens restrictions for controversial peptides popular online
The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"a 'big fan' of the drugs"
— Robert F Kennedy , Politician
Locations
All Coverage
The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.
Similar Stories
Related coverage based on topic and tags
US FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PMUltragenyx's gene therapy wins first FDA approval for rare metabolic disorder - Reuters
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder Reuters
August 19, 2026 at 10:36 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMTrump taps White House adviser Overton to lead FDA - Reuters
Trump taps White House adviser Overton to lead FDA Reuters
August 19, 2026 at 05:03 PMAs Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters
August 12, 2026 at 06:34 PM